Skip to main content
Erschienen in: Abdominal Radiology 11/2017

06.05.2017 | Commentary

Letter to the editor

verfasst von: Jonathan Lyske, Raghuram Sathyanarayana

Erschienen in: Abdominal Radiology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Excerpt

We read with interest the article by Kim et al. [1] comparing hepatocellular carcinoma (HCC) conspicuity using different image acquisition phases with gadoxetate sodium and an extracellular contrast agent. We concur with the challenge of accurate HCC detection in patients with decompensated liver disease and welcome new strategies to our diagnostic armory. However, their methodology raised several questions. …
Literatur
1.
Zurück zum Zitat Kim SY, Wu EH, Park SH, et al. (2016) Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular contrast agent. Abdom Radiol. doi:10.1007/s00261-016-0703-1 Kim SY, Wu EH, Park SH, et al. (2016) Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular contrast agent. Abdom Radiol. doi:10.​1007/​s00261-016-0703-1
2.
Zurück zum Zitat Aime S, Caravan P (2009) Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 30:1259–1267CrossRefPubMedPubMedCentral Aime S, Caravan P (2009) Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 30:1259–1267CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. RadioGraphics 31:1547–1568CrossRefPubMed Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. RadioGraphics 31:1547–1568CrossRefPubMed
4.
Zurück zum Zitat Motosugi U, Ichikawa T, Sano K, et al. (2011) Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol 46:141–145CrossRefPubMed Motosugi U, Ichikawa T, Sano K, et al. (2011) Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol 46:141–145CrossRefPubMed
5.
Zurück zum Zitat Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis of hepatocellular carcinoma: part 1. Development, growth and spread: key pathological and imaging aspects. Radiology 272:635–654CrossRefPubMedPubMedCentral Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis of hepatocellular carcinoma: part 1. Development, growth and spread: key pathological and imaging aspects. Radiology 272:635–654CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat McEvoy SH, McCarthy CJ, Lavelle LP, et al. (2013) Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American association for the study of liver diseases. RadioGraphics 33:1653–1668CrossRefPubMed McEvoy SH, McCarthy CJ, Lavelle LP, et al. (2013) Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American association for the study of liver diseases. RadioGraphics 33:1653–1668CrossRefPubMed
Metadaten
Titel
Letter to the editor
verfasst von
Jonathan Lyske
Raghuram Sathyanarayana
Publikationsdatum
06.05.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 11/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1178-4

Weitere Artikel der Ausgabe 11/2017

Abdominal Radiology 11/2017 Zur Ausgabe

Classics in Abdominal Imaging

The water lily sign

Classics in Abdominal Imaging

The football sign

Classics in Abdominal Imaging

Right posterior hepatic notch sign

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.